Associations back IMS Health in prescription data battle

US— Two research associations have registered their support for IMS Health and Verispan in their Supreme Court battle to overturn a New Hampshire law that blocks the use of physicians’ prescribing information for marketing purposes.

The Council of American Survey Research Organisations (Casro) and the Pharmaceutical Marketing Research Group (PMRG) have filed a brief in the Supreme Court in support of the two companies, claiming that the state’s prescription information law could have a “devastating effect” on the business of all pharmaceutical market research firms.

Other organisations to file briefs in support of the firms include the Coalition for Healthcare Communication and the Center for Democracy and Technology, which said the law “does not protect any legitimate privacy interest” and could “strangle” efforts to use healthcare information to improve patient care.

Two research associations have registered their support for IMS Health and Verispan in their Supreme Court battle to overturn a New Hampshire law that blocks the use of physicians’ prescribing information for marketing purposes.

Brian Tarran

The Council of American Survey Research Organisations (Casro) and the Pharmaceutical Marketing Research Group (PMRG) have filed a brief in the Supreme Court in support of the two companies, claiming that the state’s prescription information law could have a “devastating effect” on the business of all pharmaceutical market research firms.

Other organisations to file briefs in support of the firms include the Coalition for Healthcare Communication and the Center for Democracy and Technology, which said the law “does not protect any legitimate privacy interest” and could “strangle” efforts to use healthcare information to improve patient care.

Two research associations have registered their support for IMS Health and Verispan in their Supreme Court battle to overturn a New Hampshire law that blocks the use of physicians’ prescribing information for marketing purposes.

The Council of American Survey Research Organisations (Casro) and the Pharmaceutical Marketing Research Group (PMRG) have filed a brief in the Supreme Court in support of the two companies, claiming that the state’s prescription information law could have a “devastating effect” on the business of all pharmaceutical market research firms.

Other organisations to file briefs in support of the firms include the Coalition for Healthcare Communication and the Center for Democracy and Technology, which said the law “does not protect any legitimate privacy interest” and could “strangle” efforts to use healthcare information to improve patient care.

Two research associations have registered their support for IMS Health and Verispan in their Supreme Court battle to overturn a New Hampshire law that blocks the use of physicians’ prescribing information for marketing purposes.